论文部分内容阅读
老药新知红霉素最早于1952年由J.M.McG uire等人在菲律宾群岛土样中分离到的红霉素菌发酵制得,美国最先将红霉素产品推向市场。红霉素属大环内酯类抗生素,具有广谱抗菌作用,临床主要用于扁桃体炎、猩红热、白喉、皮肤软组织感染等的治疗。需要特别指出的是,红霉素对于不能耐受青霉素的患者也适用。红霉素除被收入《中国药典》外,还被收入美国、英国、日本等许多国家的药典中。
Erythromycin was first obtained from the old drug erythromycin isolated in 1952 by J.M. McG uire et al. In the soil samples of the Philippine Islands. The United States first introduced erythromycin into the market. Erythromycin is a macrolide antibiotic, with broad-spectrum antibacterial effect, clinical mainly for the treatment of tonsillitis, scarlet fever, diphtheria, skin and soft tissue infections. It is important to point out that erythromycin is also suitable for patients who can not tolerate penicillin. In addition to being included in the “Chinese Pharmacopoeia”, erythromycin is also included in the pharmacopoeias of many countries such as the United States, Britain and Japan.